| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |